Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Therapix Biosciences Ltd (TRPX)

Therapix Biosciences Ltd (TRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,113
  • Shares Outstanding, K 3,510
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,790 K
  • 60-Month Beta 0.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TRPX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/20/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.30 +5.28%
on 07/01/20
1.08 -70.65%
on 06/11/20
-0.16 (-33.56%)
since 06/01/20
3-Month
0.25 +25.69%
on 04/03/20
1.08 -70.65%
on 06/11/20
-0.03 (-7.85%)
since 04/01/20
52-Week
0.25 +25.69%
on 04/03/20
4.69 -93.24%
on 07/23/19
-2.16 (-87.22%)
since 07/01/19

Most Recent Stories

More News
Pure Capital Demands Replacement of Therapix Biosciences Ltd.'s Board of Directors

Tel Aviv, Israel, June 02, 2020 (GLOBE NEWSWIRE) -- Pure Capital today announces that it has sent a letter to the chief executive officer, chairman of the board and the directors of Therapix Biosciences...

TRPX : 0.32 (-48.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.44
1st Resistance Point 0.38
Last Price 0.32
1st Support Level 0.28
2nd Support Level 0.24
3rd Support Level N/A

See More

52-Week High 4.69
Fibonacci 61.8% 2.99
Fibonacci 50% 2.47
Fibonacci 38.2% 1.95
Last Price 0.32
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar